Expanded Medicaid tied to more thyroid cancer diagnoses
Expanded Medicaid coverage was linked to the diagnosis of more thyroid cancer...Read more on AuntMinnie.comRelated Reading: Some cancers found earlier after Medicaid expansion Medicaid expansion tied to early breast cancer diagnosis Medicaid expansion under ACA linked to fewer cancer deaths Is thyroid cancer overdiagnosed for 9/11 first responders? Medicaid expansion boosted cancer screening rates (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 18, 2020 Category: Radiology Source Type: news

iCAD touts ProFound AI Risk clinical data
Computer-aided detection (CAD) software developer iCAD is highlighting research...Read more on AuntMinnie.comRelated Reading: iCAD reports Xoft Axxent milestone iCAD features AI software for breast imaging at RSNA iCAD features Xoft Axxent upgrades at ASTRO 2019 iCAD partners with Swedish team on AI for breast cancer iCAD to highlight AI for tomosynthesis at ECR (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 17, 2020 Category: Radiology Source Type: news

Veliparib-Chemo Combo New Option for BRCA-Mutated Breast Cancer? Veliparib-Chemo Combo New Option for BRCA-Mutated Breast Cancer?
AbbVie reports that upfront veliparib maintains carboplatin-paclitaxel response, with manageable side effects.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 17, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

A New Approach To A Deadly Breast Cancer Offers Hope To The Black Women It Affects Most
Dr. Karmella Haynes is tackling resistant triple-negative breast cancer through chromatin engineering. As this cancer type disproportionately affects Black women, Haynes seeks not only to advance chromatin science but to improve health outcomes for medically underserved patients. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 17, 2020 Category: Pharmaceuticals Authors: John Cumbers, Senior Contributor Tags: Manufacturing /manufacturing Business /business Innovation /innovation Healthcare /healthcare Source Type: news

Women with DCIS have 3x the risk of breast cancer death
A new study adds weight to the belief that ductal carcinoma in situ (DCIS)...Read more on AuntMinnie.comRelated Reading: Delayed breast cancer surgery not tied to worse outcomes Preop MRI finds 11% more cancer in women with DCIS Years later, DCIS tied to more imaging but not anxiety Black women still at higher risk of breast cancer death Does imaging modality influence DCIS recurrence? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 17, 2020 Category: Radiology Source Type: news

Roche to present a broad range of data across multiple cancer types at the ESMO Virtual Congress 2020
Basel, 17 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that results from a number of studies across its broad oncology portfolio will be presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020, which will be held 19-21 September, 2020. Results include data from three phase III studies across the Tecentriq® (atezolizumab) triple-negative breast cancer (TNBC) programme. Central nervous system (CNS) efficacy data from integrated analyses of the pivotal phase II Rozlytrek® STARTRK-2, phase I STARTRK-1, and phase I ALKA-372-001 trials will be presented in addition to re...
Source: Roche Investor Update - September 17, 2020 Category: Pharmaceuticals Source Type: news

Roche to present a broad range of data across multiple cancer types at the ESMO Virtual Congress 2020
Basel, 17 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that results from a number of studies across its broad oncology portfolio will be presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020, which will be held 19-21 September, 2020. Results include data from three phase III studies across the Tecentriq® (atezolizumab) triple-negative breast cancer (TNBC) programme. Central nervous system (CNS) efficacy data from integrated analyses of the pivotal phase II Rozlytrek® STARTRK-2, phase I STARTRK-1, and phase I ALKA-372-001 trials will be presented in addition to re...
Source: Roche Media News - September 17, 2020 Category: Pharmaceuticals Source Type: news

Spotting breast cancer's spread to the brain before symptoms start could improve survival
(European Organisation for Research and Treatment of Cancer) Breast cancer patients whose disease has spread to their brains fare better if their metastases are picked up before they begin to cause symptoms, according to a study presented at the 12th European Breast Cancer Conference. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 17, 2020 Category: Cancer & Oncology Source Type: news

Pattern of gut bacteria linked to effectiveness of chemotherapy in breast cancer patients
(European Organisation for Research and Treatment of Cancer) Researchers studying the activity of gut bacteria in breast cancer patients have found a possible link with how well their chemotherapy works. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 17, 2020 Category: Cancer & Oncology Source Type: news

Spironolactone Not Tied to Breast Cancer Recurrence
Drug can be used for alopecia treatment in breast cancer survivors (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 16, 2020 Category: Cancer & Oncology Tags: Dermatology, Oncology, Pharmacy, Journal, Source Type: news

Spironolactone Not Tied to Breast Cancer Recurrence
WEDNESDAY, Sept. 16, 2020 -- Spironolactone is not independently associated with increased breast cancer recurrence, according to a study published in the October issue of the Journal of the American Academy of Dermatology. Chapman Wei, from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 16, 2020 Category: Pharmaceuticals Source Type: news

Breast cancer surgery type, quality of life among younger women
(JAMA Network) Researchers investigated differences in quality of life and other outcomes (including physical functioning, body image, sexual health, anxiety and depressive symptoms) by type of breast cancer surgery (such as mastectomy or breast conserving surgery) in women 40 and younger. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 16, 2020 Category: Cancer & Oncology Source Type: news

15.09.20: Not intended for U.S. and UK Media
Bayer and Systems Oncology sign exclusive license agreement on innovative breast cancer treatment approach ERSO™ mehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - September 16, 2020 Category: Pharmaceuticals Source Type: news

Seattle Genetics strikes potential $4.2B deal for breast cancer drug
Seattle Genetics announced Monday a deal with New Jersey-based Merck& Co. Inc. to globally develop a drug that targets breast cancer and other solid tumors. The drug is currently in Phase 2 trials. Merck will pay $600 million upfront and make a $1 billion equity investment in 5 million shares of Seattle Genetics’ common stock at a price of $200 per share. Additionally, Seattle Genetics is eligible for progress-dependent milestone payments of up to $2.6 billion, including $850 million in de velopment… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 15, 2020 Category: Pharmaceuticals Authors: Megan Campbell Source Type: news

Seattle Genetics strikes potential $4.2B deal for breast cancer drug
Seattle Genetics announced Monday a deal with New Jersey-based Merck& Co. Inc. to globally develop a drug that targets breast cancer and other solid tumors currently in Phase 2 trials. Merck will pay $600 million upfront and make a $1 billion equity investment in 5 million shares of Seattle Genetics’ common stock at a price of $200 per share. Additionally, Seattle Genetics is eligible for progress-dependent milestone payments of up to $2.6 billion, including $850 million in de velopment milestones… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 15, 2020 Category: Biotechnology Authors: Megan Campbell Source Type: news

Linking integrins and EVs in metastasis
Integrins mediate the uptake of extracellular vesicles into breast cancer cells. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - September 15, 2020 Category: Science Authors: Ferrarelli, L. K. Tags: STKE Editors ' Choice Source Type: news

Gilead to buy East Coast breast cancer-focused biotech in $21 billion deal
Peninsula biotech giant Gilead Sciences, Inc. has continued to bolster its cancer drug portfolio, this time with a huge purchase of a New Jersey breast cancer drugmaker. Foster City-based Gilead (NASDAQ: GILD) announced Sunday that it and Immunomedics (NASDAQ: IMMU) had entered into an all-cash agreement where Gilead would acquire the East Coast biotech for $88 per share. The transaction, which values Immunomedics at approximately $21 billion and was unanimously a pproved by both Gilead and Immunomedics'… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 14, 2020 Category: Pharmaceuticals Authors: Ted Andersen Source Type: news

Gilead to buy East Coast breast cancer-focused biotech in $21 billion deal
Peninsula biotech giant Gilead Sciences, Inc. has continued to bolster its cancer drug portfolio, this time with a huge purchase of a New Jersey breast cancer drugmaker. Foster City-based Gilead (NASDAQ: GILD) announced Sunday that it and Immunomedics (NASDAQ: IMMU) had entered into an all-cash agreement where Gilead would acquire the East Coast biotech for $88 per share. The transaction, which values Immunomedics at approximately $21 billion and was unanimously a pproved by both Gilead and Immunomedics'… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 14, 2020 Category: Biotechnology Authors: Ted Andersen Source Type: news

Anesthesia and Circulating Tumor Cells in Breast Cancer Anesthesia and Circulating Tumor Cells in Breast Cancer
Does the type of anesthesia administered during breast cancer surgery impact postoperative circulating tumor cell counts?Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 14, 2020 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Fighting breast cancer with nanotech, immunotherapy  
(Case Western Reserve University) Scientists led by a   researcher at the Case Western Reserve University   School of Medicine   are making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy. Efstathios " Stathis " Karathanasis,   an associate professor of biomedical engineering,   is directing the novel technique--sending nanoparticles into the body to wake up " cold " tumors so they can be located and neutralized by immune cells. The team also includes researchers from Cleveland Clinic and Duke University. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 14, 2020 Category: International Medicine & Public Health Source Type: news

Boston University researchers to develop new breast tumor models
(Boston University School of Medicine) Boston University School of Medicine (BUSM) researchers Gerald Denis, PhD, Andrew Emili, PhD, and Stefano Monti, PhD, together with Beth Israel Deaconess/Harvard Medical School researcher Senthil Muthuswamy, PhD, have been awarded a five-year, $2.5 million National Cancer Institute UO1 grant to develop and analyze breast tumor organoids (models). Specifically, the award will support their project: Multiscale analysis of metabolic inflammation as a driver of breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 14, 2020 Category: Cancer & Oncology Source Type: news

Should mother's milk be produced in the lab?
Human milk grown from mammary cells could liberate breastfeeding women – but it’s a controversial sellOne of the saddest things about being diagnosed with breast cancer a few years ago (it was fortunately treatable) was having to stop breastfeeding my 10-month-old baby. Unceremoniously she was shunted on to an early diet of pure solid food, which I reasoned was probably just as nutritious as infant formula and the best solution in the absence of donor milk from a breast-milk bank, which is reserved for premature and ill babies, and dispensed by prescription.Baby Agnes thrived, but what if there were another opt...
Source: Guardian Unlimited Science - September 13, 2020 Category: Science Authors: Zo ë Corbyn Tags: Science Breastfeeding Parents and parenting Family Breast cancer Health & wellbeing Society Life and style Source Type: news

Vaping DOES raise the risk of breast cancer, warn scientists
Scientists from a group of American universities found that exposure to e-cigarette vapour (file image) creates a 'tumour-promoting environment' in the breast and elsewhere in the body. (Source: the Mail online | Health)
Source: the Mail online | Health - September 12, 2020 Category: Consumer Health News Source Type: news

'Like having a tooth out': High-speed radiotherapy cured mother-of-two's breast cancer in 30 minutes
A breast cancer diagnosis once meant life had to be put on hold. Months of treatment and countless trips to hospital typically followed. But for Jane Putley, 51, from London, it was over in a flash. (Source: the Mail online | Health)
Source: the Mail online | Health - September 12, 2020 Category: Consumer Health News Source Type: news

Cancer Projects to Diversify Genetic Research Receive New Grants
Because much cancer research and clinical trials have been based on white populations, efforts to explore the ways race and ethnicity influence disease are underway. (Source: NYT Health)
Source: NYT Health - September 11, 2020 Category: Consumer Health News Authors: Emma Goldberg Tags: Race and Ethnicity Colon and Colorectal Cancer Pancreatic Cancer Bladder Cancer Breast Cancer Black People Genetics and Heredity Cold Spring Harbor Laboratory Dana-Farber Cancer Institute Memorial Sloan-Kettering Cancer Center Mount Si Source Type: news

Gene Testing for Patients With Breast Cancer and Second Cancer Gene Testing for Patients With Breast Cancer and Second Cancer
All breast cancer patients who develop a 2nd primary cancer should undergo multigene panel testing. The authors note that women with breast cancer have a 4%-16% lifetime risk of a second primary cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 10, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Do breast screening guidelines overlook Black women?
Guidelines that recommend breast screening beginning at age 50 could leave...Read more on AuntMinnie.comRelated Reading: Hormone receptor-positive cancers on the rise Medicaid expansion tied to early breast cancer diagnosis Black women still at higher risk of breast cancer death Racial factors affect time to breast cancer treatment Black women have worse breast cancer outcomes (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 10, 2020 Category: Radiology Source Type: news

Major trial uses blood test to match women with breast cancer to precision treatments
(Institute of Cancer Research) A blood test that can identify a variety of mutations in advanced breast cancer can reliably match women to effective targeted treatments, early results of a major clinical trial reveal. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 10, 2020 Category: Cancer & Oncology Source Type: news

Featured Reviews: Behavioural activation therapy for depression
How well does behavioural activation therapy work for depression in adults?  And what about the effects of this treatment on depression for adults with long‐term physical conditions? Two new Cochrane systematic reviews look at the available evidence.Depression is a common mental health problem. It can cause a persistent feeling of sadness and loss of interest in people, activities, and things that were once enjoyable. Treatments for depression include psychological therapies (talking therapies). Two reviews recently published byCochrane Common Mental Disordersfocus on a type of psychological therapy called behaviour...
Source: Cochrane News and Events - September 9, 2020 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Atezolizumab TNBC Indication'in Jeopardy' From Phase 3 Results Atezolizumab TNBC Indication'in Jeopardy' From Phase 3 Results
Atezolizumab plus paclitaxel is ineffective in patients with previously untreated, inoperable, locally advanced or metastatic triple-negative breast cancer, according to the FDA.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 9, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Breast cancer missed in hundreds of women due to covid cancellations
Hundreds of women with breast cancer in London were not picked up by routine screening as services closed during the lockdown, officials have estimated. (Source: HSJ)
Source: HSJ - September 9, 2020 Category: UK Health Source Type: news

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
(Johns Hopkins Medicine) Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 9, 2020 Category: Cancer & Oncology Source Type: news

Oxford University researchers discover 'genetic vulnerability' in breast cancer cells
(University of Oxford) The study, published in the scientific journal Nature, has uncovered a genetic vulnerability present in nearly 10% percent of all breast cancers tumours, and found a way to target this vulnerability and selectively kill cancer cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 9, 2020 Category: Cancer & Oncology Source Type: news

Hair loss drug spironolactone may be safe for use in breast cancer survivors
(George Washington University) Researchers at the George Washington University have found that the hair loss drug spironolactone is not associated with increased risk of female breast cancer recurrence and may be safe to treat female pattern hair loss in breast cancer survivors. Their findings are published in the Journal of the American Academy of Dermatology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 9, 2020 Category: Cancer & Oncology Source Type: news

FDA issues alert about efficacy and potential safety concerns with atezolizumab in combination with paclitaxel for treatment of breast cancer  
FDA issues alert about efficacy and potential safety concerns with atezolizumab in combination with paclitaxel for treatment of breast cancer   (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 8, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA alerts health care professionals and oncology clinical investigators about efficacy and potential safety concerns with atezolizumab in combination with paclitaxel for treatment of breast cancer
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 8, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Protein causes mutations that lead to breast cancer cell aggression
(University of Alberta Faculty of Medicine& Dentistry) In her previous research, University of Alberta biochemist Ing Swie Goping identified that the protein, BCL-2 interacting killer (BIK), was associated with relapses in breast cancer patients. In a new study published in the journal Cell Death and Disease, she found that the problem lies with the cellular 'self-destruct' process of apoptosis. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 8, 2020 Category: Biology Source Type: news

Thermal imaging enhances engineers' understanding of breast tumors
(University of Texas at Dallas) New research performed at The University of Texas at Dallas and published June 22 in Nature Research's Scientific Reports takes a critical step toward making digital infrared thermal imaging more useful for monitoring breast cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 8, 2020 Category: International Medicine & Public Health Source Type: news

Featured Review: Taxation of the fat content of foods for reducing their consumption and preventing obesity or other adverse health outcomes
ConclusionsWe did not find enough reliable evidence to find out whether a tax on the fat content of foods resulted in people eating less fat, or less saturated fat.We did not find any evidence about how a tax on the fat content of foods affected obesity or overweight.The results of our review will change when further evidence becomes available.Discussing the findings of this review, lead author Stefan Lhachimi said, “A tax on saturated fats could be in principle a good approach to reduce the consumption of so-called junk foods, a group of food products which is fiendishly tricky to define in legal terms. By taxing a ...
Source: Cochrane News and Events - September 7, 2020 Category: Information Technology Authors: Rachel Klabunde Source Type: news

Breast cancer symptoms: Three warning signs of the deadly disease
BREAST cancer is the most common cancer in the UK - one woman is diagnosed with the deadly disease every 10 minutes. This could affect your partner, a member of your family, yourself or a dear friend. Here are the three warning signs of the condition. (Source: Daily Express - Health)
Source: Daily Express - Health - September 6, 2020 Category: Consumer Health News Source Type: news

Early puberty may increase breast cancer risk
According to a study published in theJournal of Adolescent Health, girls who start puberty earlier than average, due to higher levels of growth hormone, may have an increased risk of developing breast cancer as adults.News Medical (Source: Society for Endocrinology)
Source: Society for Endocrinology - September 4, 2020 Category: Endocrinology Source Type: news

Mason researchers to provide bioinformatic analysis
(George Mason University) Virginia Espina, Research Associate Professor, Applied Proteomics and Molecular Medicine, received $21,000 from Baylor Research Institute for a project in which Mason researchers are providing biostatistics and bioinformatic analysis for integrating multi-omic data sets from a breast cancer cohort. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 4, 2020 Category: International Medicine & Public Health Source Type: news

Ultrasound vs. mammo: What's best for lactating women?
Ultrasound may be the ideal imaging modality for evaluating palpable breast...Read more on AuntMinnie.comRelated Reading: Breast MRI effective for postpartum breast cancer Screening US boosts cancer detection rate in high-risk women MR features delineate invasive breast cancer in lactating women Breast abscesses in the clear with ultrasound-guided drainage Strict attention to detail enhances sensitivity of breast US (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 3, 2020 Category: Radiology Source Type: news

Dual-phase technique improves PET/CT brain tumor imaging
Using a dual-phase technique with F-18 FDG PET/CT -- that is, performing the...Read more on AuntMinnie.comRelated Reading: PET/CT could be useful for diagnosing fever SNMMI 2020: PSMA-PET/CT changes prostate cancer management SNMMI 2020: PET tracer could image, treat glioblastoma PET/CT confirms breast cancer predicted by blood markers New PET/CT tracer reliably detects prostate cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 3, 2020 Category: Radiology Source Type: news

Hair dye and cancer risk: Largest study yet
(Medical University of Vienna) Studies have indicated that people who dye their hair regularly may have a higher risk of cancer, especially bladder cancer and breast cancer. Hair dyes contain certain chemicals that have been held responsible for these relationships. In the largest study to date, which followed 117,200 women from the USA over 36 years, this could not be confirmed. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 3, 2020 Category: Cancer & Oncology Source Type: news

Precise geometry enables specialized protein to turn genes on
New research maps how GATA3, a protein associated with breast cancer, binds and remodels DNA. (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - September 2, 2020 Category: Environmental Health Source Type: news

Black children less likely to get proton radiotherapy
Black children enrolled in national clinical trials are three times less likely...Read more on AuntMinnie.comRelated Reading: RSNA article calls on radiology to commit to equity SBI, ASER, SIR join groups weighing in on racial injustice More societies issue statements on racial injustice Insurance plays major role in breast cancer disparities Same-day breast biopsies reduce healthcare disparities (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 2, 2020 Category: Radiology Source Type: news

Researchers awarded $2 million grant to study the immune system and triple negative breast cancer
(University of Tennessee Health Science Center) Liza Makowski, Ph.D., a professor in the Department of Medicine-Hematology-Oncology at the University of Tennessee Health Science Center, and Joseph F. Pierre, PhD, an assistant professor in the Department of Pediatrics-Obesity at UTHSC, have received $2.1 million from the National Cancer Institute for a five-year study to examine how the microbiome impacts the immune system and response to immunotherapy for an aggressive type of breast cancer called triple negative breast cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 2, 2020 Category: International Medicine & Public Health Source Type: news

Growth hormone plays key role in early puberty, breast cancer risk
(Cincinnati Children's Hospital Medical Center) Girls who enter puberty early in life--as measured by early breast development and age of first menstrual period--have a longer window of susceptibility to breast cancer. This window stays propped open for too long because their bodies have higher concentrations of growth hormone and they experience a slower progression ('tempo') during puberty. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 1, 2020 Category: Cancer & Oncology Source Type: news

Venom from honeybees found to kill aggressive breast cancer cells
(Harry Perkins Institute of Medical Research) Honeybee venom induces cancer cell death in hard to treat triple-negative breast cancer with minimal effect on healthy cells (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 1, 2020 Category: Cancer & Oncology Source Type: news